Siemens Healthineers (SMMNY.PK) reported Wednesday that its fourth-quarter net income grew 15 percent to 624 million euros from last year's 540 million euros.
Basic earnings per share were 0.55 euro, up 14 percent from prior year's 0.48 euro. Adjusted basic earnings per share were 0.67 euro, compared to last year's 0.60 euro.
In the quarter, adjusted EBIT, a key earnings metric, grew 7 percent to 1.12 billion euros from last year's 1.05 billion euros.
Adjusted EBIT margin was 17.7 percent, compared to last year's 17.2 percent.
Revenue increased 4.5 percent to 6.33 billion euros from 6.06 billion euros in the prior year. Comparable revenue growth was 5.6 percent. Excluding the rapid COVID-19 antigen-test business, which ended in the prioryear quarter, comparable revenue growth was 6.5 percent.
Further, the company proposed dividend of 0.95 euro per share for the year, unchanged from the prior year.
Looking ahead, for fiscal year 2025, Siemens Healthineers expects adjusted basic earnings per share to be between 2.35 euros and 2.50 euros, and comparable revenue growth of between 5 percent to 6 percent.
In fiscal year 2024, adjusted basic earnings per share were 2.23, with comparable revenue growth of 4.7 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.